Clinical trial
Clinical Trial Ceftriaxone in Subjects With ALS
NCT00349622 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00349622 |
|---|---|
| Title | Clinical Trial Ceftriaxone in Subjects With ALS |
| Official title | Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS) |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Amyotrophic Lateral Sclerosis, ALS |
| Intervention type | Drug, Other |
| Interventions | ceftriaxone, placebo |
| Enrollment | 513 |
| Start date | Jul 1, 2006 |
| Primary completion | Nov 1, 2012 |
| Completion | Nov 1, 2012 |
| First posted | Jul 7, 2006 |
| Last update posted | Apr 21, 2014 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: